- Home
- DVAX vs UHAL Comparison
DVAX vs UHAL Comparison
Compare DVAX & UHAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVAX
- UHAL
- Stock Information
- Founded
- DVAX 1996
- UHAL 1945
- Country
- DVAX United States
- UHAL United States
- Employees
- DVAX N/A
- UHAL N/A
- Industry
- DVAX Biotechnology: Pharmaceutical Preparations
- UHAL Rental/Leasing Companies
- Sector
- DVAX Health Care
- UHAL Consumer Discretionary
- Exchange
- DVAX Nasdaq
- UHAL Nasdaq
- Market Cap
- DVAX 1.3B
- UHAL 11.2B
- IPO Year
- DVAX 2004
- UHAL N/A
- Fundamental
- Price
- DVAX $9.41
- UHAL $57.50
- Analyst Decision
- DVAX Buy
- UHAL
- Analyst Count
- DVAX 4
- UHAL 0
- Target Price
- DVAX $26.50
- UHAL N/A
- AVG Volume (30 Days)
- DVAX 1.9M
- UHAL 130.6K
- Earning Date
- DVAX 11-06-2025
- UHAL 11-05-2025
- Dividend Yield
- DVAX N/A
- UHAL N/A
- EPS Growth
- DVAX N/A
- UHAL N/A
- EPS
- DVAX N/A
- UHAL 1.60
- Revenue
- DVAX $316,268,000.00
- UHAL $5,910,645,000.00
- Revenue This Year
- DVAX $23.23
- UHAL $3.13
- Revenue Next Year
- DVAX $16.57
- UHAL $3.69
- P/E Ratio
- DVAX N/A
- UHAL $35.92
- Revenue Growth
- DVAX 26.66
- UHAL 4.91
- 52 Week Low
- DVAX $9.22
- UHAL $56.25
- 52 Week High
- DVAX $14.63
- UHAL $79.04
- Technical
- Relative Strength Index (RSI)
- DVAX 33.66
- UHAL 46.63
- Support Level
- DVAX $9.51
- UHAL $57.38
- Resistance Level
- DVAX $9.94
- UHAL $58.89
- Average True Range (ATR)
- DVAX 0.29
- UHAL 1.31
- MACD
- DVAX -0.07
- UHAL 0.16
- Stochastic Oscillator
- DVAX 0.85
- UHAL 33.20
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
About UHAL U-Haul Holding Company
U-Haul Holding Co is an American moving truck, trailer, and self-storage rental company. The company also provides moving boxes, packing supplies, LPG (propane) refills, trailer hitch and wiring installation, storage container rentals, and other services. It has three reportable segments Moving and Storage, Property and Casualty Insurance, and Life Insurance. The majority of its revenue comes from the Moving and Storage segment.